Biora Therapeutics, Inc. Cash Flow Quality Index
Latest as of September 2024:
-0.10x
Biora Therapeutics, Inc. cash flow quality index. Biora Therapeutics, Inc. (BIORQ) has a Cash Flow Quality Index of -0.10x as of September 2024. Operating cash flow of $-8.73 Million is below net income of $90.56 Million, suggesting accrual-heavy earnings not yet converted to cash. See Biora Therapeutics, Inc. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-0.10x
Operating CF / Net Income
Operating Cash Flow
$-8.73 Million
USD
Net Income
$90.56 Million
USD
Data as of
Sep 2024
Most recent filing
Biora Therapeutics, Inc. Cash Flow Quality Index by Year (None–None)
Biora Therapeutics, Inc. cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Biora Therapeutics, Inc.. For the full cash flow conversion analysis, see BIORQ cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.